TipRanks
pc:orbis

Orbis Medicines

Copenhagen, DK
https://www.orbismedicines.com/
Orbis Medicines is focused on the development of next-generation oral macrocycle drugs, utilizing its proprietary nGen platform. The platform leverages automated chemistry and machine learning to systematically design oral macrocycles, initially targeting validated blockbuster biologic targets.

Leadership & Board

Current Number of Employees45
Current LinkedIn Followers6,302

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$90M
Total Amount Raised$90M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$90M
Latest Funding Amount$90M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Company Momentum Positive

Articles Published on TipRanks2
Articles Published on TipRanks
2
LinkedIn Trend+6.24% followers
LinkedIn Trend
+6.24% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Orbis Medicines LinkedIn following is declining, suggesting reduced market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

Orbis Medicines had 45 employees as of September 21, 2026. The number of employees increased by 0 (0.00%) week-over-week.
45Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Orbis Medicines had 6,302 followers as of September 21, 2026. The number of followers increased by 370 (6.24%) week-over-week.
6,302Latest Followers Count
370(6.24%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$90.00M
―

Investors

Similar Companies

A snapshot of private companies similar to Orbis Medicines, helping you discover and navigate related company profiles.

Related News and Analysis